* Clover Health Investments Corp CLOV.OQ reported a
quarterly
adjusted loss of 16 cents per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 24 cents per share.
* Revenue rose 100.6% to $856.82 million from a year ago;
analysts
expected $799.46 million.
* Clover Health Investments Corp's reported EPS for the
quarter
was a loss of 16 cents.
* The mean earnings estimate of analysts had fallen by
about 13.8%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Clover Health Investments Corp shares had fallen by 19.4%
this
quarter and lost 63.2% so far this year.
* The company reported a quarterly loss of $75.31 million.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $3.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
7 at 10:02 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.24 -0.16 Beat
Jun. 30 2022 -0.21 -0.22 Missed
Mar. 31 2022 -0.27 -0.19 Beat
Dec. 31 2021 -0.26 -0.28 Missed